Literature DB >> 23942924

Measuring clinical trial-associated workload in a community clinical oncology program.

Marjorie J Good1, Barbara Lubejko, Keisha Humphries, Andrea Medders.   

Abstract

PURPOSE: The ability to quantify clinical trial-associated workload can have a significant impact on the efficiency and success of a research organization. However, methods to effectively estimate the number of research staff needed for clinical trial recruitment, maintenance, compliance, and follow-up are lacking. To address this need, the Wichita Community Clinical Oncology Program (WCCOP) developed and implemented an acuity-based workload assessment tool to facilitate assessment and balancing of workload among its research nursing staff.
METHODS: An acuity-based measurement tool was developed, assigning acuity scores for individual clinical trials using six trial-related determinants. Using trial acuity scores and numbers of patients per trial, acuity scores for individual research nursing staff were then calculated and compared on a monthly basis.
RESULTS: During the 11 years that data were collected, acuity scores increased from 65% to 181%. However, during this same period, WCCOP was able to decrease individual research nurse staff full-time equivalent (FTE) acuity scores and number of patients per FTE. These trends reflect the use of the acuity-based measurement tool to determine actual workload and use of the acuity data to direct hiring decisions.
CONCLUSION: Clinical trial workload has been successfully measured and used to guide staffing by one community clinical oncology program. Further research is needed regarding its applicability to other research programs.

Entities:  

Mesh:

Year:  2013        PMID: 23942924      PMCID: PMC3710172          DOI: 10.1200/JOP.2012.000797

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  8 in total

1.  Understanding patient classification systems.

Authors:  P Giovannetti
Journal:  J Nurs Adm       Date:  1979-02       Impact factor: 1.737

2.  A systems approach to the management of nursing services--Part II: Patient classification system.

Authors:  A Van Slyck
Journal:  Nurs Manage       Date:  1991-04

3.  Assessing the impact of protocol design changes on clinical trial performance.

Authors:  Kenneth A Getz; Julia Wenger; Rafael A Campo; Edward S Seguine; Kenneth I Kaitin
Journal:  Am J Ther       Date:  2008 Sep-Oct       Impact factor: 2.688

4.  Ontario protocol assessment level: clinical trial complexity rating tool for workload planning in oncology clinical trials.

Authors:  Bobbi Smuck; Phyllis Bettello; Koralee Berghout; Tracie Hanna; Brenda Kowaleski; Lynda Phippard; Diana Au; Kay Friel
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

Review 5.  Creating an effort tracking tool to improve therapeutic cancer clinical trials workload management and budgeting.

Authors:  Pam James; Patty Bebee; Linda Beekman; David Browning; Mathew Innes; Jeannie Kain; Theresa Royce-Westcott; Marcy Waldinger
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

Review 6.  Productivity and workload measurement in ambulatory oncology.

Authors:  B R Medvec
Journal:  Semin Oncol Nurs       Date:  1994-11       Impact factor: 2.315

7.  Chemotherapy drug administration: a beginning survey of chemotherapy as a workload index.

Authors:  S Campbell; L Hallgren; V Kamitomo; C Catedral
Journal:  Cancer Nurs       Date:  1984-06       Impact factor: 2.592

8.  Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  Kathyrn Roche; Nancy Paul; Bobbi Smuck; Marlo Whitehead; Benny Zee; Joseph Pater; Mary-Anne Hiatt; Hugh Walker
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

  8 in total
  9 in total

1.  Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.

Authors:  Eileen P Dimond; Robin T Zon; Bryan J Weiner; Diane St Germain; Andrea M Denicoff; Kandie Dempsey; Angela C Carrigan; Randall W Teal; Marjorie J Good; Worta McCaskill-Stevens; Stephen S Grubbs; Eileen P Dimond; Robin T Zon; Bryan J Weiner; Diane St Germain; Andrea M Denicoff; Kandie Dempsey; Angela C Carrigan; Randall W Teal; Marjorie J Good; Worta McCaskill-Stevens; Stephen S Grubbs
Journal:  J Oncol Pract       Date:  2015-12-01       Impact factor: 3.840

2. 

Authors:  Mai N Hong; K Alix Hayden; Shelley Raffin Bouchal; Shane Sinclair
Journal:  Can Oncol Nurs J       Date:  2021-05-01

3.  Oncology clinical trials nursing: A scoping review.

Authors:  Mai N Hong; Alix Hayden; Shelley Raffin Bouchal; Shane Sinclair
Journal:  Can Oncol Nurs J       Date:  2021-05-01

4.  Increasing complexity in oncology phase I clinical trials.

Authors:  Laeeq Malik; David Lu
Journal:  Invest New Drugs       Date:  2018-11-16       Impact factor: 3.850

5.  Assessing Clinical Trial-Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool.

Authors:  Marjorie J Good; Patricia Hurley; Kaitlin M Woo; Connie Szczepanek; Teresa Stewart; Nicholas Robert; Alan Lyss; Mithat Gönen; Rogerio Lilenbaum
Journal:  J Oncol Pract       Date:  2016-03-22       Impact factor: 3.840

6.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

Review 7.  Benchmarks for Academic Oncology Faculty.

Authors:  Lowell Anthony; George Atweh; Ravi Bhatia; Lisa A Carey; Jenny C Chang; Martin J Edelman; Philip W Kantoff; Merry Jennifer Markham; Wells Messersmith; Edward L Nelson; Kurt Oettel; Ruth O'Regan; Claire F Verschraegen; Julie M Vose
Journal:  JCO Oncol Pract       Date:  2020-09-30

8.  NCI-Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center.

Authors:  Daniel J Kim; Dan Otap; Nora Ruel; Naveen Gupta; Naveed Khan; Tanya Dorff
Journal:  J Clin Med       Date:  2020-06-24       Impact factor: 4.241

9.  Factors associated with recruitment success in the phase 2a study of aztreonam-avibactam development programme: a descriptive qualitative analysis among sites in Spain.

Authors:  Rosa M Jimenez-Rodriguez; Guillermo Martín-Gutiérrez; Silvia Jiménez-Jorge; Clara M Rosso-Fernández; Luis Tallón-Aguilar; Cristina Roca-Oporto; Javier Padillo; Alison Luckey; Angela Cano; José López-Ruiz; Silvia Gómez-Zorrilla; Jaime Bonnín-Pascual; Lucía Boix-Palop; José Miguel Montejo; Julian Torre-Cisneros; José Miguel Cisneros
Journal:  BMJ Open       Date:  2022-02-03       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.